SCHEMBL16531690

SCHEMBL16531690

Cn1ncc(Br)c1-c1cc(NC(=O)ON2CCc3ccc(Cl)cc32)ccc1OCCN

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 20/20 0.57
▸ HTR2C P28335 15/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16531662 0.94 HTR2A (0.57) HTR2AHTR2C
SCHEMBL885445 0.89 HTR2A (0.60) HTR2AHTR2C
SCHEMBL16530874 0.88 HTR2A (0.52) HTR2AHTR2C
SCHEMBL16531558 0.86 HTR2A (0.54) HTR2AHTR2C
SCHEMBL16531742 0.86 HTR2A (0.54) HTR2AHTR2C
SCHEMBL885683 0.85 HTR2A (0.60) HTR2AHTR2C
SCHEMBL16531720 0.82 HTR2A (0.58) HTR2AHTR2C
SCHEMBL16531412 0.80 HTR2A (0.57) HTR2AHTR2C
SCHEMBL20778743 0.80 HTR2A (0.57) HTR2AHTR2C
SCHEMBL16531733 0.80 HTR2A (0.54) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018371-B1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2015-03-04 — — EP claimed
US-8945510-B2 Radiolabeled glutaminyl cyclase (QC) inhibitors and uses of same PROBIODRUG AG (DE) 2015-02-03 — — US disclosed
Send feedback